FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...

Nexalin’s growing body of published data consistently demonstrates objective normalization of abnormal brain activity and ...

Add Yahoo as a preferred source to see more of our stories on Google. Chinese researchers have unveiled the world’s first battery-powered, wearable repetitive transcranial magnetic stimulation (rTMS) ...

A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for treating attention-deficit/hyperactivity disorder, does not effectively ...

In A Nutshell • A brain stimulation device cleared by the FDA in 2019 failed to beat placebo in a rigorous 150-participant ...

The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies that ...

“To the best of our team's knowledge, this project represents the first time an Alabama medical center has examined deep brain stimulation for depression,” said Matthew Macaluso, D.O., director of the ...

The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...

MAITLAND, Fla., Nov. 5, 2025 /PRNewswire/ -- Those seeking help with depression or other mental health concerns can access breakthrough, medication-free support at Foundations at Maitland. The ...

There is no cure for Parkinson's, and over one million people have the disease in the United States alone. However, deep brain stimulation (DBS) has been used to treat this and other neurological ...

The procedure helps many keep movement disorders at bay but also poses dangers. May 1, 2010— -- Adding deep brain stimulation to medical therapy for Parkinson's disease improved symptoms and ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms. The ...